Sector: Pharmaceuticals & Biotechnology

Mid Cap

Sun Pharma Advanced Share Price

Q: What is the current share price of Sun Pharma Advanced Research Company Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Sun Pharma Advanced Research Company Ltd. is ₹ 265 on the NSE and ₹ 264.3 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

Q: What is the Market Capitalization of Sun Pharma Advanced Research Company Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Sun Pharma Advanced Research Company Ltd. is approximately ₹ 9007.7 Cr.

Q: What are the PE and PB ratios for Sun Pharma Advanced Research Company Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Sun Pharma Advanced Research Company Ltd. is 5.8, and the Price-to-Book (PB) ratio is 6.7.

Q: What is the 52-Week High and Low for Sun Pharma Advanced Research Company Ltd.?

Over the past 52 weeks, the highest price reached by Sun Pharma Advanced Research Company Ltd. shares was ₹ 289, and the lowest price was ₹ 108.

Q: Who are the major shareholders of Sun Pharma Advanced Research Company Ltd.?

Significant shareholdings in Sun Pharma Advanced Research Company Ltd. typically include entities such as: Promoter Public FII Mutual Funds Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Sun Pharma Advanced Research Company Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Sun Pharma Advanced Research Company Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

SPARC

₹265

-12.57(-4.53%)

10th Jul 2026 | 3:28 PM

NSE : SPARC

Open Free Demat Account

Sun Pharma Advanced Performance

Price Movement

₹265.00

₹258.62

₹280.50

↘ Today's Low↗ Today's High

1 Year Performance

₹265.00

₹108.00

₹289.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹280.50

Low₹258.62

Open at₹279.80

Prev Close₹277.57

Volumes29.44 L

Avg Price₹266.53

Lower Circuit₹249.82

Upper Circuit₹305.32

Historical Performance

3M High₹289.00

3M Low₹118.68

1 Yr High₹289.00

1 Yr Low₹108.00

3 Yr High₹472.80

3 Yr Low₹108.00

5 Yr High₹472.80

5 Yr Low₹108.00

Summary

As of 10-07-2026 18:05, Sun Pharma Advanced Research Company Ltd. share price today is ₹0, with a change of ₹-277.57 (-100.00%) from the previous close of ₹277.57. The stock opened at ₹279.8 and traded between ₹258.62 and ₹280.5, with a total traded volume of 2943608 shares. The company has a market capitalization of ₹9007.7 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹289 and ₹108, respectively.

Sun Pharma Advanced Research Company Ltd. valuation metrics include a P/E ratio of 5.8, EPS of ₹47.86, and book value of ₹6.70. Profitability indicators show ROE of 116.01%. Sun Pharma Advanced Research Company Ltd. has reported revenue of ₹1879.17 Cr and net profit of ₹1553.2 Cr.

Sun Pharma Advanced Research Company Ltd. technical indicators include Day RSI at 78.61, Day MFI at 73.49, Day ADX at 44.65. Additional indicators include Commodity Channel Index (CCI) at 219.1 and Williams %R at -16.58. Momentum indicators show Day MACD at 16.72, Day MACD Signal Line at 14.12, DayATR at 13.84. Rate of Change indicators for Sun Pharma Advanced Research Company Ltd. include ROC125 at 104.52 and ROC21 at 32.69.

Exponential moving averages include EMA5 at ₹264.6, EMA10 at ₹254, EMA12 at ₹251, EMA20 at ₹240.9, EMA26 at ₹234.3, EMA50 at ₹212.1, EMA100 at ₹185.6, EMA200 at ₹168.1. Simple moving averages include SMA5 at ₹263, SMA10 at ₹248.3, SMA20 at ₹239.9, SMA30 at ₹229.5, SMA50 at ₹206.4, SMA100 at ₹168.2, SMA150 at ₹157.5, SMA200 at ₹151.6.

Support levels for Sun Pharma Advanced are placed at First Support ₹270.28, Second Support ₹262.99, Third Support ₹255.78. Resistance levels are seen at First Resistance ₹284.78, Second Resistance ₹291.99, Third Resistance ₹299.28. Sun Pharma Advanced Research Company Ltd. shareholding pattern shows promoter holding at 65.67%, FII holding at 2.04%, DII holding at 0%, public holding at 31.4%.

Sun Pharma Advanced Fundamentals

Market Cap

Above industry Median

9,007.70 Cr.

PE Ratio (TTM)

Low in industry

5.80

Dividend Yield

Net Profit TTM

553.5% incr over last year

1,553.20

Net Profit Growth

553.5% incr over last year

1,553.20

PEG Ratio

Below industry Median

ROE

116.01

Operating Revenue TTM

1,879.17

Operating Revenue Growth

2518.3% incr over last year

Book Value

High in industry

6.70

MFI

MFI Overbought

73.49

RSI

RSI Overbought

78.61

EPS (TTM)

47.86

Debt to Equity

0.42

Face Value

Operating Profit Margin Qtr.

84.59

Operating Profit Qtr.

1,773.20

Net Profit Qtr.

1,761.34

Operating Revenue Qtr.

1,853.22

PB Ratio

6.70

Sun Pharma Advanced Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	1,853.22	8.45	7.86	9.64	27.19
Operating Expense	80.28	65.32	73.75	61.97	81.11
Operating Profit	1,772.94	-56.87	-65.89	-52.33	-53.92
Depreciation	2.40	2.56	2.57	2.54	2.55
Interest	11.64	8.78	7.52	6.18	4.51
Tax	0	0	0	0	0
Net Profit	1,760.70	-80.57	-75.97	-52.03	-60.98

Sun Pharma Advanced Technicals

Sun Pharma Advanced Research Company Ltd. EMA & SMA

₹265.00

-4.98 (-1.84%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹264.6

Day EMA10 ₹254

Day EMA12 ₹251

Day EMA20 ₹240.9

Day EMA26 ₹234.3

Day EMA50 ₹212.1

Day EMA100 ₹185.6

Day EMA200 ₹168.1

Sun Pharma Advanced Support and Resistance

Resistance

First Resistance₹284.78

Second Resistance₹291.99

Third Resistance₹299.28

Support

First Support₹270.28

Second Support₹262.99

Third Support₹255.78

Technical Indicators

Day RSI78.61

Day MFI73.49

Day ADX44.65

Day Commodity Channel Index219.10

William-16.58

Day MACD16.72

Day MACD Signal Line14.12

Day ATR13.84

Day ROC125104.52

Day ROC2132.69

Sun Pharma Advanced Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	65.7	65.7	65.7	65.7	65.7	65.7
FII	2.2	1.4	1.5	1.8	2	2
DII	0.7	1.2	0.9	1	0.8	0.9
Public	31.5	31.8	28.4	31.5	31.5	31.4

Sun Pharma Advanced Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	10.05 L	33.15 L	30.32%
Week	16.89 L	61.54 L	27.45%
1 Month	12.05 L	38.53 L	31.28%
6 Month	9.95 L	41.79 L	23.81%

Sun Pharma Advanced SWOT Analysis

Strengths43

Weakness1

Opportunity1

Threats1

High DVM Mid and Small Caps (subscription)

Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Profit making Companies with High ROCE and Low PE

Companies with 10% increase in share price over three months, with rising net profit growth

Undervalued Growth Stocks

Strong Momentum: Price above short, medium and long term moving averages

Jim Slater's Zulu Principle (Discover Growth Stocks)

Relative Outperformance versus Industry over 1 Month

Momentum Play Screener - Weekly Screener

Rising Net Cash Flow and Cash from Operating activity

Affordable Stocks with High ROE and Momentum

Affordable stocks with good momentum and ROE - All Stocks (subscription)

Strong QoQ EPS Growth in recent results

Companies that saw improvement in net profits, operating profit margin and revenues in the most recent quarter

Stringent DVM Screener

Combined DVM and Piotroski Scores Screener (subscription)

Weekly Screener: High Momentum Score Stocks (subscription)

Higher DVM Stocks Among Midcaps and Largecaps

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Turnaround companies- loss to profit QoQ

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

Stock gained more than 20% in one month

Highest Recovery from 52 Week Low

Stock with Low PE (PE < = 10)

Top Gainers

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Sun Pharma Advanced Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Sun Pharma Advanced Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	Senores Pharmaceuticals Ltd.	OneSource Specialty Pharma Ltd.	Sanofi Consumer Healthcare India Ltd.	Akums Drugs & Pharmaceuticals Ltd.
Price (₹)	₹2,044	₹825	₹1,410.10	₹1,625.50	₹4,565	₹704.20
% Change	1.05%	2.83%	-0.68%	-0.01%	1.30%	6.99%
Revenue TTM (₹ Cr)	₹1,403.18	₹642.26	₹649.50	₹1,421.59	₹935	₹4,359.02
Net Profit TTM (₹ Cr)	₹185.12	₹172.89	₹115.38	₹-73.80	₹257.90	₹255.19
PE TTM	66.80	52.40	56.70	-252.60	40.20	40.60
1 Year Return	90.47	35.3	141.77	-19.54	-13.64	17.17
ROCE	31.54	24.22	15.60	0.59	-	11.40

Similar Stocks

INNOVACAP

Innova Captab Ltd.

₹ 990.00

-0.09%

BLUEJET

Blue Jet Healthcare Ltd

₹ 622.50

+8.36%

CONCORDBIO

Concord Biotech Ltd.

₹ 1304.50

-0.07%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 709.35

+0.91%

SUPRIYA

Supriya Lifescience Ltd.

₹ 856.00

-2.16%

ALIVUS

Alivus Life Sciences Ltd.

₹ 1159.90

+1.49%

COHANCE

Cohance Lifesciences Ltd.

₹ 452.00

+2.69%

ERIS

Eris Lifesciences Ltd.

₹ 1426.20

-0.27%

SYNGENE

Syngene International Ltd.

₹ 422.40

+1.69%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 838.00

+2.58%

STAR

Strides Pharma Science Ltd.

₹ 1083.00

+0.65%

FDC

FDC Ltd.

₹ 432.60

+0.12%

SHILPAMED

Shilpa Medicare Ltd.

₹ 626.90

+0.74%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 969.00

-0.02%

NATCOPHARM

Natco Pharma Ltd.

₹ 983.70

+2.30%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 2599.90

-0.82%

MARKSANS

Marksans Pharma Ltd.

₹ 270.50

-2.45%

ORCHPHARMA

Orchid Pharma Ltd.

₹ 1008.00

-4.09%

BLISSGVS

Bliss GVS Pharma Ltd.

₹ 522.40

-0.33%

SANOFI

Sanofi India Ltd.

₹ 3415.00

+1.76%

PGHL

Procter & Gamble Health Ltd.

₹ 6800.00

+2.84%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 591.00

-0.10%

FAQ's on SPARC

What is the current share price of Sun Pharma Advanced Research Company Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Sun Pharma Advanced Research Company Ltd. is ₹ 265 on the NSE and ₹ 264.3 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Sun Pharma Advanced Research Company Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Sun Pharma Advanced Research Company Ltd. is approximately ₹ 9007.7 Cr.

What are the PE and PB ratios for Sun Pharma Advanced Research Company Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Sun Pharma Advanced Research Company Ltd. is 5.8, and the Price-to-Book (PB) ratio is 6.7.

What is the 52-Week High and Low for Sun Pharma Advanced Research Company Ltd.?

Over the past 52 weeks, the highest price reached by Sun Pharma Advanced Research Company Ltd. shares was ₹ 289, and the lowest price was ₹ 108.

Who are the major shareholders of Sun Pharma Advanced Research Company Ltd.?

Significant shareholdings in Sun Pharma Advanced Research Company Ltd. typically include entities such as:

Promoter
Public
FII
Mutual Funds
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Sun Pharma Advanced Research Company Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Sun Pharma Advanced Research Company Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy